Cargando…
Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions
Small vessel disease encompasses lacunar stroke, white matter hyperintensities, lacunes and microbleeds. It causes a quarter of all ischemic strokes, is the commonest cause of vascular dementia, and the cause is incompletely understood. Vascular prophylaxis, as appropriate for large artery disease a...
Autores principales: | Bath, Philip M., Wardlaw, Joanna M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832291/ https://www.ncbi.nlm.nih.gov/pubmed/25727737 http://dx.doi.org/10.1111/ijs.12466 |
Ejemplares similares
-
Clinical management of cerebral small vessel disease: a call for a holistic approach
por: Clancy, Una, et al.
Publicado: (2021) -
Cilostazol and isosorbide mononitrate for the prevention of progression of cerebral small vessel disease: baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)
por: Bath, Philip M, et al.
Publicado: (2022) -
Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two
repurposed licenced drugs to prevent progression of cerebral small vessel
disease
por: Wardlaw, Joanna, et al.
Publicado: (2020) -
Update on cerebral small vessel disease: a dynamic whole-brain disease
por: Shi, Yulu, et al.
Publicado: (2016) -
Advanced Neuroimaging of Cerebral Small Vessel Disease
por: Blair, Gordon W., et al.
Publicado: (2017)